Polyethylene Glycol 3350 Powder, For Solution
NDC Package 72657-196-16
Package Information
Polyethylene Glycol 3350 powders is •do not take more than directed unless advised by your doctor•the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)•adults and children 17 years of age and older:ouse once a dayofill to top of white section in cap which is marked to indicate the correct dose (17 g)ostir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drinkodo not combine with starch-based thickeners used for difficulty swallowingoensure that the powder is fully dissolved before drinkingodo not drink if there are any clumpsodo not use more than 7 days•children 16 years of age or under: ask a doctor. This formulation utilizes a powder, for solution delivery system. Marketed by Glenmark Therapeutics Inc., Usa, this product is identified by NDC 72657-196 and is authorized under FDA application ANDA203928.
Identification & Billing
- RxCUI: 876193 - polyethylene glycol 3350 17 GM Powder for Oral Solution
- RxCUI: 876193 - polyethylene glycol 3350 17000 MG Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72657 - Glenmark Therapeutics Inc., Usa
- 72657-196 - Polyethylene Glycol 3350
- 72657-196-16 - 765 g in 1 CAN
- 72657-196 - Polyethylene Glycol 3350
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72657-196-16 identifies a specific commercial package of 765 g in 1 can of Polyethylene Glycol 3350, a human over the counter drug labeled by Glenmark Therapeutics Inc., Usa. This product is billed per "GM" gram and contains an estimated amount of 765 billable units per package. This powder, for solution is formulated for oral use and contains polyethylene glycol 3350 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Therapeutics Inc., Usa on September 19, 2024. The current certification is valid through December 31, 2027.
How is this Glenmark Therapeutics Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72657019616. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 765 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.